169 related articles for article (PubMed ID: 8552419)
1. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.
al-Yaman F; Genton B; Anders R; Taraika J; Ginny M; Mellor S; Alpers MP
Parasite Immunol; 1995 Sep; 17(9):493-501. PubMed ID: 8552419
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status.
al-Yaman F; Genton B; Taraika J; Anders R; Alpers MP
Parasite Immunol; 1997 May; 19(5):207-14. PubMed ID: 9194097
[TBL] [Abstract][Full Text] [Related]
4. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea.
al-Yaman F; Genton B; Falk M; Anders RF; Lewis D; Hii J; Beck HP; Alpers MP
Am J Trop Med Hyg; 1995 Jan; 52(1):66-71. PubMed ID: 7856827
[TBL] [Abstract][Full Text] [Related]
5. Strain-specific humoral response to a polymorphic malaria vaccine.
Flück C; Smith T; Beck HP; Irion A; Betuela I; Alpers MP; Anders R; Saul A; Genton B; Felger I
Infect Immun; 2004 Nov; 72(11):6300-5. PubMed ID: 15501757
[TBL] [Abstract][Full Text] [Related]
6. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea.
al-Yaman F; Genton B; Anders RF; Falk M; Triglia T; Lewis D; Hii J; Beck HP; Alpers MP
Am J Trop Med Hyg; 1994 Nov; 51(5):593-602. PubMed ID: 7985752
[TBL] [Abstract][Full Text] [Related]
7. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
Taylor RR; Allen SJ; Greenwood BM; Riley EM
Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
Galindo CM; Acosta CJ; Schellenberg D; Aponte JJ; Roca A; Oettli A; Urassa H; Armstrong Schellenberg J; Kahigwa E; Ascaso C; Mshinda H; Lwilla F; Vidal J; Menendez C; Tanner M; Alonso PL
Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea.
Genton B; Al-Yaman F; Anders R; Saul A; Brown G; Pye D; Irving DO; Briggs WR; Mai A; Ginny M; Adiguma T; Rare L; Giddy A; Reber-Liske R; Stuerchler D; Alpers MP
Vaccine; 2000 May; 18(23):2504-11. PubMed ID: 10775784
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
[TBL] [Abstract][Full Text] [Related]
11. Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area.
al-Yaman F; Genton B; Taraika J; Anders R; Alpers MP
Parasite Immunol; 1997 Jun; 19(6):249-54. PubMed ID: 9364554
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
[TBL] [Abstract][Full Text] [Related]
13. Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea.
Stirnadel HA; Beck HP; Alpers MP; Smith TA
Genet Epidemiol; 1999; 17(1):16-34. PubMed ID: 10323182
[TBL] [Abstract][Full Text] [Related]
14. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
[TBL] [Abstract][Full Text] [Related]
15. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
[TBL] [Abstract][Full Text] [Related]
16. WITHDRAWN: Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
[TBL] [Abstract][Full Text] [Related]
17. Impact of red blood cell polymorphisms on the antibody response to Plasmodium falciparum in Senegal.
Sarr JB; Pelleau S; Toly C; Guitard J; Konaté L; Deloron P; Garcia A; Migot-Nabias F
Microbes Infect; 2006 Apr; 8(5):1260-8. PubMed ID: 16679042
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
19. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
Malar J; 2011 May; 10():108. PubMed ID: 21529376
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria.
Badaut C; Guyonnet L; Milet J; Renard E; Durand R; Viwami F; Sagbo G; Layla F; Deloron P; Bonnefoy S; Migot-Nabias F
Malar J; 2015 Jul; 14():278. PubMed ID: 26178656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
